MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
about
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
@en
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer
@nl
type
label
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
@en
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer
@nl
prefLabel
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
@en
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer
@nl
P1050
P3098
NCT03004105
P580
2018-05-01T00:00:00Z
P6220
250b8bf0-e1cf-11e6-b886-0242ac120006